Peptides - Metabolic

Semaglutide

GLP-1 agonist for weight management and metabolic optimization

Fat LossHormone OptimizationCompare

Dosage

0.25-2.4mg weekly

Results

4-12 weeks

Frequency

Weekly

Cost

$200-400/month

Estimated monthly

$200-400

About Semaglutide

Semaglutide is a GLP-1 receptor agonist FDA-approved as Ozempic for diabetes and Wegovy for weight management. It works by mimicking the GLP-1 hormone, which regulates appetite and blood sugar. Clinical trials have shown it can help achieve significant, sustained weight loss when combined with lifestyle changes.

Administration

Method

Subcutaneous injection

Timing

Food

Any time

Key Benefits

Effective weight loss
Appetite suppression
Improved glycemic control
Cardiovascular protection
FDA-approved

Stacks Well With

Tesamorelin

FDA-approved GHRH analog that targets visceral fat

MOTS-c

Mitochondrial-derived peptide that enhances metabolic function

Cagrilintide

Long-acting amylin analog that reduces appetite and enhances weight loss when combined with semaglutide

Important Considerations

• MEN2
• Thyroid cancer history
• Pancreatitis
• Pregnancy

Additional Notes

• FDA-approved as Ozempic/Wegovy
• Start low and titrate

Research & Studies

Semaglutide: STEP 1 Weight Loss Trial Results

2021·Clinical Trial

Semaglutide: Cardiovascular Outcomes in T2D

2016·Clinical Trial

Research provided for educational purposes. Always consult a healthcare provider.